THE KPM GROUP DC LLC

Lobbying for MAHZI THERAPEUTICS · Focused on treating under‐served rare genetic neurodevelopmental disorders

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$20,000.00

What the client paid this registrant for the period.

Client based in

California

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 3

Medical/Disease Research/Clinical Labs

Priority review voucher (PRV) re-authorization, ICD-10 codes

Health Issues

Priority review voucher (PRV) re-authorization, ICD-10 codes

Science/Technology

Priority review voucher (PRV) re-authorization, ICD-10 codes

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.